Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microbial lectome versus host glycolipidome: How pathogens exploit glycosphingolipids to invade, dupe or kill. | Front Microbiol | 2022 | 36060781 | PubTator, text mining | PubMed |
| Efficacy of CRISPR-Based Gene Editing in a Sickle Cell Disease Patient as Measured through the Eye. | Case Rep Hematol | 2022 | 36046774 | PubTator, text mining | PubMed |
| A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation. | Acta Biomed | 2022 | 36043958 | PubTator, text mining | PubMed |
| Time Domains of Hypoxia Responses and -Omics Insights. | Front Physiol | 2022 | 36035495 | PubTator, text mining | PubMed |
| Research progress and applications of nanobody in human infectious diseases. | Front Pharmacol | 2022 | 36034845 | PubTator, text mining | PubMed |
| Translational potential of base-editing tools for gene therapy of monogenic diseases. | Front Bioeng Biotechnol | 2022 | 36032737 | PubTator, text mining | PubMed |
| Rotavirus C Replication in Porcine Intestinal Enteroids Reveals Roles for Cellular Cholesterol and Sialic Acids. | Viruses | 2022 | 36016447 | PubTator, text mining | PubMed |
| Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy. | J Clin Med | 2022 | 36013014 | PubTator, text mining | PubMed |
| Enhancer-Mediated Formation of Nuclear Transcription Initiation Domains. | Int J Mol Sci | 2022 | 36012554 | PubTator, text mining | PubMed |
| Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. | Nat Commun | 2022 | 36008377 | PubTator, text mining | PubMed |
| In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies. | JCI Insight | 2022 | 36006707 | PubTator, text mining | PubMed |
| Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression. | Front Cardiovasc Med | 2022 | 35990977 | PubTator, text mining | PubMed |
| Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications. | Sci Rep | 2022 | 35982069 | PubTator, text mining | PubMed |
| [Molecular Epidemiological Characteristics and Differential Diagnosis of Common δβ-Thalassemia/HPFH]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2022 | 35981381 | PubTator, text mining | PubMed |
| RS12574989 and haplotype associated with α/β-chain imbalance and population HbA2 reduction. | BMC Med Genomics | 2022 | 35971149 | PubTator, text mining | PubMed |
| Age-restricted functional and developmental differences of neonatal platelets. | J Thromb Haemost | 2022 | 35962592 | PubTator, text mining | PubMed |
| Efficacy and Safety of Hydroxyurea as Adjuvant Therapy in Pediatric Patients of Transfusion-Dependent Beta-Thalassemia Major at Zhob, Balochistan. | Cureus | 2022 | 35959173 | PubTator, text mining | PubMed |
| Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases. | Front Genome Ed | 2022 | 35958050 | PubTator, text mining | PubMed |
| Deletion of Meg8-DMR Enhances Migration and Invasion of MLTC-1 Depending on the CTCF Binding Sites. | Int J Mol Sci | 2022 | 35955961 | PubTator, text mining | PubMed |
| Artemisia argyi exhibits anti-aging effects through decreasing the senescence in aging stem cells. | Aging (Albany NY) | 2022 | 35951373 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=30